Source:http://linkedlifedata.com/resource/pubmed/id/11730480
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 3
|
pubmed:dateCreated |
2001-12-3
|
pubmed:abstractText |
The human placenta is a rich raw material for production of many biopharmaceutical products. Here we describe a co-purification process for the production of four different proteins from haemolysed human placenta blood: IgG, catalase (Cat), superoxide dismutase (Sod) and albumin (Alb). The process can be divided in two parts: the common steps and the specific separation techniques for each protein. The common steps are: extraction, haemoglobin precipitation, concentration/diafiltration and the first Q-Sepharose chromatography step. At this chromatography step the process is branched: while IgG and Cat were recovered in the flow-through, Sod and Alb were eluted separately. IgG and Cat were separated in a second Q-Sepharose chromatography step during which IgG was recovered in the flow-through, whereas Cat bound to the resin. IgG was purified by S-Sepharose chromatography, followed by selective precipitation with n-octanoic acid, yielding about 0.4 g of IgG per kg of placenta. Cat was eluted at the second Q-Sepharose chromatography step and was purified by Blue Sepharose chromatography. A total of 1.8 x 10(6) units of Cat were recovered/kg of placenta, with a specific activity of 45000 units/mg of protein. Sod was further purified by S-Sepharose and Phenyl-Sepharose chromatography steps and recovered in the non-adsorbed fractions. The yield of Sod was 2.1 x 10(5) units/kg of placenta, with a specific activity of 1194 units/mg of protein. Alb purification was followed by a combined process including thermocoagulation and treatment with activated charcoal. The final step was Phenyl-Sepharose chromatography. The process yielded 3.1 g of Alb/kg of placenta. The described methodology was designed to be easily scaled-up for industrial production.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0885-4513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
135-42
|
pubmed:dateRevised |
2007-3-21
|
pubmed:meshHeading |
pubmed-meshheading:11730480-Blood,
pubmed-meshheading:11730480-Blood Chemical Analysis,
pubmed-meshheading:11730480-Catalase,
pubmed-meshheading:11730480-Chromatography, Agarose,
pubmed-meshheading:11730480-Hemolysis,
pubmed-meshheading:11730480-Humans,
pubmed-meshheading:11730480-Immunoglobulin G,
pubmed-meshheading:11730480-Placenta,
pubmed-meshheading:11730480-Serum Albumin,
pubmed-meshheading:11730480-Superoxide Dismutase
|
pubmed:year |
2001
|
pubmed:articleTitle |
An associated process for the purification of immuno globulin G, catalase, superoxide dismutase and albumin from haemolysed human placenta blood.
|
pubmed:affiliation |
Instituto Butantan, Centro de Biotecnologia, Av. Vital Brasil 1500, CEP 05503-900, São Paulo, SP, Brazil. sgrellet@usp.br
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|